Malaria surveillance - United States, 2012

MMWR Surveillance Summaries

Volumn 63, Issue 1, 2014, Pages 1-22

  Cullen, Karen A ^a   Arguin, Paul M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; CHILD; DRUG RESISTANCE; FEMALE; HEALTH SURVEY; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALARIA; MALE; MIDDLE AGED; PLASMODIUM; PREGNANCY; PRESCHOOL CHILD; SEASON; SEVERITY OF ILLNESS INDEX; SOLDIER; STATISTICS AND NUMERICAL DATA; TRAVEL; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED; MILITARY PERSONNEL; PLASMODIUM; POPULATION SURVEILLANCE; PREGNANCY; SEASONS; SEVERITY OF ILLNESS INDEX; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84921953647     PISSN: 15460738     EISSN: 15458636     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. World Health Organization. World malaria report 2013. Geneva, Switzerland: WHO Press; 2013.
2. Pan American Health Organization. Report for registration of malaria eradication from United States of America. Washington, DC: Pan American Health Organization; 1969.
3. Andrews JM, Quinby GE, Langmuir AD. Malaria eradication in the United States. Am J Public Health 1950;40:1405-11.
4. Mckay T, Bianco T, Rhodes L, Barnett S. Prevalence of Dirofilaria immitis (Nematoda: Filarioidea) in mosquitoes from northeast Arkansas, the United States. Journal of Medical Entomology. 2013;50:871-8.
5. CDC. Malaria Surveillance-United States, 2011. MMWR 2013;62(No. SS-5).
6. CDC. Local transmission of Plasmodium vivax malaria-Palm Beach County, Florida, 2003. MMWR 2003;52:908-11.
7. Leder K, Black J, O'Brien D, et al. Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis 2004;39:1104-12.
8. CDC. National notifiable disease surveillance system. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at: http://wwwn.cdc.gov/nndss/default.aspx.
9. Council of State and Territorial Epidemiologists. Public Health Reporting and National Notifiction for Malaria. Atlanta, GA: Council of State and Territorial Epidemiologists. Available at http://c.ymcdn.com/sites/www. cste.org/resource/resmgr/PS/09-ID-47.pdf. 2009.
10. World Health Organization. Terminology of malaria and of malaria eradication: report of a drafting committee. Geneva, Switzerland: World Health Organization; 1963.
11. World Health Organization. Management of severe malaria: a practical handbook. Third ed. Geneva, Switzerland: WHO Press; 2012.
12. CDC. Malaria Surveillance-United States, 2009. MMWR 2011;60(No. SS-3).
13. BinaxNOW® Malaria [package insert]. Scarborough, Maine: Inverness Medical Professional Diagnostics; 2007.
14. CDC. Malaria rapid diagnostic test. MMWR 2007;56:686.
15. Bacon DJ, McCollum AM, Griffing SM, et al. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 2009;53:2042-51.
16. Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother 2000;44:2100-8.
17. Price RN, Uhlemann AC, Brockman A, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004;364:438-47.
18. Takala-Harrison S, Clark TG, Jacob CG, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A 2012;110:240-5.
19. Ariey F, Witkowski B, Amaratunga C, Beghain J, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014;505:50-5.
20. CDC. Malaria Surveillance-United States, 2010. MMWR 2012;61(No. SS-2).
21. World Tourism Organization. UNWTO Tourism Highlights, 2013 Edition. Madrid, Spain: UNWTO Publications; 2013. Available at http://www.e-unwto.org/content/q27534/fulltext.pdf.
22. Armed Forces Health Surveillance Center. Update: Malaria, U.S. Armed Forces, 2012. Medical Surveillance Monthly Report 2013;20:2-5.
23. CDC. Guidelines for treatment of malaria in the United States. July 1, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf.
24. Plucinski MM, Huber CS, Akinyi S, et al. Novel mutation in cytochrome b of Plasmodium falciparum in one of two atovaquone-proguanil treatment failures in travelers returning from same site in Nigeria. Open Forum Infectious Diseases 2014;in press.
25. Dobson M. The history of malaria in England. London, England: Wellcome Trust; 1999. Available at http://malaria.wellcome.ac.uk/doc_wtd023991.html.
26. Public Health England. Malaria cases fall across the UK. London, England: Public Health England; 2013. Available at https://www.gov. uk/government/news/malaria-cases-fall-across-the-uk.
27. World Tourism Organization. UNWTO Tourism Highlights, 2012 Edition. Madrid, Spain: UNWTO Publications; 2012. Available at http://www.e-unwto.org/content/x6k11g/fulltext.pdf.
28. Baggett HC, Graham S, Kozarsky PE, et al. Pretravel health preparation among US residents traveling to India to VFRs: importance of ethnicity in defining VFRs. Journal of Travel Medicine 2009;16:112-8.
29. Balaban V, Warnock E, Ramana Dhara V, Jean-Louis LA, Sotir MJ, Kozarsky P. Health risks, travel preparation, and illness among public health professionals during international travel. Travel Medicine and Infectious Disease 2014;12:349-54.
30. Landman KZ, Tan KR, Arguin PM. Knowledge, attitides, and practices regarding antimalarial chemoprophylaxis in US Peace Corps volunteers- Africa, 2013. MMWR 2014;63:516-7.
31. Selent M, de Rochars VMB, Stanek D, et al. Malaria prevention knowledge, attitudes, and practices (KAP) among international flying pilots and flight attendants of a US commercial airline. Journal of Travel Medicine 2012;19:366-72.
32. Diara M, Nowosiwsky A, Harmen S, Burke N, Alilio M. Enabling factors for improved malaria chemoprophylaxis compliance. Am J Trop Med Hyg 2012;87:960-1.
33. Council of State and Territorial Epidemiologists. Public health reporting and national notifiction for malaria. Atlanta, GA: Council of State and Territorial Epidemiologist. Available at http://c.ymcdn.com/sites/www. cste.org/resource/resmgr/PS/13-ID-08.pdf. 2013.
34. Pan American Health Organization. Status of malaria eradication in the Americas, 18th report. PAHO CSP 18/7. Washington, DC: Pan American Health Organization; 1970. Available at http://new.paho.org/hq/index.php?lang=en.
35. Agarwal A, McMorrow M, Arguin PM. The increase of imported malaria acquired in Haiti among US travelers in 2010. Am J Trop Med Hyg 2012;86:9-10.
36. Townes D, Existe A, Boncy J, et al. Malaria survey in post-earthquake Haiti-2010. Am J Trop Med Hyg 2012;86:29-31.
37. CDC. Immigrants returning home to visit friends and relatives (VFRs). In: CDC Health information for international travel 2012. New York: Oxford University Press 2012:547-51.
38. Londono BL, Eisele TP, Keating J, et al. Chloroquine-resistant haplotype Plasmodium falciparum parasites, Haiti. Emerg Infect Dis 2009;15:735-40.
39. Londono-Renteria B, Eisele TP, Keating J, Bennett A, Krogstad DJ. Genetic diversity in the merozoite surface protein 1 and 2 genes of Plasmodium falciparum from the Artibonite Valley of Haiti. Acta Tropica 2012;121:6-12.
40. The Global Fund. Ten countries rally to eliminate malaria in Central America and the Caribbean. 2013. Geneva, Switzerland: The Global Fund; 2013. Available at http://www.theglobalfund.org/en/mediacenter/newsreleases/2013-06-28_Ten_Countries_Rally_to_Eliminate_ Malaria_in_Central_America_and_the_Caribbean.
41. CDC. Malaria Surveillance-United States, 2004. MMWR 2006;55(No. SS-4).
42. Herwaldt BL, Juranek DD. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg 1993;48:313-23.
43. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 2001;14:659-88.
44. Alweis RL, DiRosario K, Conidi G, Kain KC, Olans R, Tully JL. Serial nosocomial transmission of Plasmodium falciparum malaria from patient to nurse to patient. Infect Control Hosp Epidemiol 2004;25:55-9.
45. Jain SK, Persaud D, Perl TM, Pass MA, Murphy KM, Pisciotta JM, et al. Nosocomial malaria and saline flush. Emerg Infect Dis 2005;11:1097-9.
46. Brisson M, Brisson P. Compliance with antimalaria chemoprophylaxis in a combat zone. Am J Trop Med Hyg 2012;86:587-90.
47. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: A systematic review. JAMA 2007;297:2264-77.
48. CDC. Primaquine shortage. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at http://www.cdc.gov/malaria/new_info/2011/primaquine.html.
49. CDC. Primaquine now available. Atlanta, GA: US Department of Health and Human Services; 2012. Available at http://www.cdc.gov/malaria/new_info/2012/primaquine.html.
50. CDC. Malaria Diagnosis (United States). Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at: http://www. cdc.gov/malaria/diagnosis_treatment/diagnosis.html.
51. Baird JK. Effectiveness of antimalarial drugs. New Engl J Med 2005;352:1565-77.
52. Abanyie FA, Arguin PM, Gutman J. State of malaria diagnostic testing at clinical laboratories in the United States, 2010: a nationwide survey. Malaria Journal 2011;10:340.
53. CDC. New medication for severe malaria available under an investigational new drug protocol. MMWR 2007;56:769-73.